Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
261studies shown
Showing 145-156 of 261
Drug study icon
CompletedEUCTR 2015-005282-22

JNJ-42847922 for Depression

This study is completed in France, in Germany, in Finland, .... It is testing JNJ-42847922 for Depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
France, Germany, Finland, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Drug study icon
Active Not RecruitingNCT07199179

Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia

This observational study is following people with Depression - depression, Depression Disorder, or Suicide to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 64 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Depression
Behavioral study icon
CompletedNCT03605524

Olfactory Training and Emotional State

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
University Hospital, Tours
Condition
Depression
Drug study icon
CompletedNCT06806475

Sustained Ketamine Effectiveness for Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Depression, Suicidality
Drug study icon
CompletedEUCTR 2016-004422-42

3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine for Depression

This study is completed in France, in Belgium, in Hungary, .... It is testing 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine for Depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
France, Belgium, Hungary, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.